The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Phosphorylation of SOX9 by Cyclic AMP-Dependent Protein Kinase A Enhances SOX9's Ability To Transactivate a Col2a1 Chondrocyte-Specific Enhancer
Open accessAbstract
Sox9 is a high-mobility-group domain-containing transcription factor required for chondrocyte differentiation and cartilage formation. We used a yeast two-hybrid method based on Son of Sevenless (SOS) recruitment to screen a chondrocyte cDNA library and found that the catalytic subunit of cyclic AMP (cAMP)-dependent protein kinase A (PKA-Calpha) interacted specifically with SOX9. Next we found that two consensus PKA phosphorylation sites within SOX9 could be phosphorylated by PKA in vitro and that SOX9 could be phosphorylated by PKA-Calpha in vivo. In COS-7 cells cotransfected with PKA-Calpha and SOX9 expression plasmids, PKA enhanced the phosphorylation of wild-type SOX9 but did not affect phosphorylation of a SOX9 protein in which the two PKA phosphorylation sites (S(64) and S(211)) were mutated. Using a phosphospecific antibody that specifically recognized SOX9 phosphorylated at serine 211, one of the two PKA phosphorylation sites, we demonstrated that addition of cAMP to chondrocytes strongly increased the phosphorylation of endogenous Sox9. In addition, immunohistochemistry of mouse embryo hind legs showed that Sox9 phosphorylated at serine 211 was principally localized in the prehypertrophic zone of the growth plate, corresponding to the major site of expression of the parathyroid hormone-related peptide (PTHrP) receptor. Since cAMP has previously been shown to effectively increase the mRNA levels of Col2a1 and other specific markers of chondrocyte differentiation in culture, we then asked whether PKA phosphorylation could modulate the activity of SOX9. Addition of 8-bromo-cAMP to chondrocytes in culture increased the activity of a transiently transfected SOX9-dependent 48-bp Col2a1 chondrocyte-specific enhancer; similarly, cotransfection of PKA-Calpha increased the activity of this enhancer. Mutations of the two PKA phosphorylation consensus sites of SOX9 markedly decreased the PKA-Calpha activation of this enhancer by SOX9. PKA phosphorylation and the mutations in the consensus PKA phosphorylation sites of SOX9 did not alter its nuclear localization. In vitro phosphorylation of SOX9 by PKA resulted in more efficient DNA binding. We conclude that SOX9 is a target of cAMP signaling and that phosphorylation of SOX9 by PKA enhances its transcriptional and DNA-binding activity. Because PTHrP signaling is mediated by cAMP, our results support the hypothesis that Sox9 is a target of PTHrP signaling in the growth plate and that the increased activity of Sox9 might mediate the effect of PTHrP in maintaining the cells as nonhypertrophic chondrocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sox9 is required for cartilage formation
Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R., & de Crombrugghe, B. (1999) · Nature Genetics · doi:10.1038/8792 · Cited by 1,758
Self-citationWagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, J., Hustert, E., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90041-8 · Cited by 1,618
Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
Foster, J. W., Dominguez-Steglich, M. A., Guioli, S., Kwok, C., Weller, P. A., Stevanović, M., Weissenbach, J., Mansour, S., Young, I. D., Goodfellow, P. N., et al. (1994) · Nature · doi:10.1038/372525a0 · Cited by 1,612
PTH/PTHrP Receptor in Early Development and Indian Hedgehog—Regulated Bone Growth
Lanske, B., Karaplis, A. C., Lee, K., Luz, A., Vortkamp, A., Pirro, A., Karperien, M., Defize, L. H. K., Ho, C., Mulligan, R. C., et al. (1996) · Science · doi:10.1126/science.273.5275.663 · Cited by 1,325
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.
Karaplis, A. C., Luz, A., Glowacki, J., Bronson, R. T., Tybulewicz, V. L., Kronenberg, H. M., & Mulligan, R. C. (1994) · Genes & Development · doi:10.1101/gad.8.3.277 · Cited by 1,153
SOX9 Is a Potent Activator of the Chondrocyte-Specific Enhancer of the Proα1(II) Collagen Gene
Lefebvre, V., Huang, W., Harley, V. R., Goodfellow, P. N., & de Crombrugghe, B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2336 · Cited by 1,076
Self-citationSOX9 directly regulates the type-ll collagen gene
Bell, D. M., Leung, K. K. H., Wheatley, S. C., Ng, L. J., Zhou, S., Wing Ling, K., Har Sham, M., Koopman, P., Tam, P. P. L., & Cheah, K. S. E. (1997) · Nature Genetics · doi:10.1038/ng0697-174 · Cited by 933
Lefebvre, V., Li, P., & de Crombrugghe, B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5718 · Cited by 811
Self-citationda Silva, S. M., Hacker, A., Harley, V., Goodfellow, P., Swain, A., & Lovell-Badge, R. (1996) · Nature Genetics · doi:10.1038/ng0996-62 · Cited by 795
Cited by
Endochondral ossification: How cartilage is converted into bone in the developing skeleton
Mackie, E. J., Ahmed, Y. A., Tatarczuch, L., Chen, K.-S., & Mirams, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.009 · Cited by 1,022
The Transcription Factors L-Sox5 and Sox6 Are Essential for Cartilage Formation
Smits, P., Li, P., Mandel, J., Zhang, Z., Deng, J. M., Behringer, R. R., de Crombrugghe, B., & Lefebvre, V. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00003-x · Cited by 598
Self-citationKozhemyakina, E., Lassar, A. B., & Zelzer, E. (2015) · Development · doi:10.1242/dev.105536 · Cited by 544
Transcriptional mechanisms of chondrocyte differentiation
de Crombrugghe, B., Lefebvre, V., Behringer, R. R., Bi, W., Murakami, S., & Huang, W. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00094-9 · Cited by 472
Self-citationLefebvre, V., Dumitriu, B., Penzo-Méndez, A., Han, Y., & Pallavi, B. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.05.019 · Cited by 467
Self-citationRegulatory mechanisms in the pathways of cartilage and bone formation
de Crombrugghe, B., Lefebvre, V., & Nakashima, K. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00276-3 · Cited by 461
Self-citationMackie, E. J., Tatarczuch, L., & Mirams, M. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0048 · Cited by 433
Molecular mechanisms of endochondral bone development
Provot, S., & Schipani, E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.068 · Cited by 375
Physiological Substrates of cAMP-Dependent Protein Kinase
Shabb, J. B. (2001) · Chemical Reviews · doi:10.1021/cr000236l · Cited by 373
The versatile functions of Sox9 in development, stem cells, and human diseases
Jo, A., Denduluri, S., Zhang, B., Wang, Z., Yin, L., Yan, Z., Kang, R., Shi, L. L., Mok, J., Lee, M. J., et al. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.004 · Cited by 366
Iyengar, P., Combs, T. P., Shah, S. J., Gouon-Evans, V., Pollard, J. W., Albanese, C., Flanagan, L., Tenniswood, M. P., Guha, C., Lisanti, M. P., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206737 · Cited by 363
SOX9 and the many facets of its regulation in the chondrocyte lineage
Lefebvre, V., & Dvir-Ginzberg, M. (2017) · Connective Tissue Research · doi:10.1080/03008207.2016.1183667 · Cited by 347
Self-citationDemoor, M., Ollitrault, D., Gomez-Leduc, T., Bouyoucef, M., Hervieu, M., Fabre, H., Lafont, J., Denoix, J.-M., Audigié, F., Mallein-Gerin, F., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.02.030 · Cited by 296
BMP Receptor Signaling Is Required for Postnatal Maintenance of Articular Cartilage
Rountree, R. B., Schoor, M., Chen, H., Marks, M. E., Harley, V., Mishina, Y., & Kingsley, D. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020355 · Cited by 288
Control of chondrogenesis by the transcription factor Sox9
Akiyama, H. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0048-x · Cited by 285
SOX9 in cartilage development and disease
Lefebvre, V., Angelozzi, M., & Haseeb, A. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.07.008 · Cited by 268
Self-citationHarley, V. R., Clarkson, M. J., & Argentaro, A. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0025 · Cited by 259
The Signaling Pathways Involved in Chondrocyte Differentiation and Hypertrophic Differentiation
Li, J., & Dong, S. (2016) · Stem Cells International · doi:10.1155/2016/2470351 · Cited by 170
“For example, the catalytic subunit of cyclic AMP-(cAMP-) dependent protein kinase A increases the activity of Sox9 and the inhibition of protein kinase A blocks the chondrocyte differentiation [130, 131].”
SOX9 modulates the expression of key transcription factors required for heart valve development
Garside, V. C., Cullum, R., Alder, O., Lu, D. Y., Vander Werff, R., Bilenky, M., Zhao, Y., Jones, S. J. M., Marra, M. A., Underhill, T. M., et al. (2015) · Development · doi:10.1242/dev.125252 · Cited by 65
Metadata
- Authors
- Huang, W., Zhou, X., Lefebvre, V., & de Crombrugghe, B.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2000-06-01
- Volume
- 20
- Issue
- 11
- Pages
- 4149-4158
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2140963908
- Cited by
- 282
- References
- 33
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.